Credit Suisse’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-308
| Closed | -$133K | – | 3515 |
|
|
2019
Q3 | $133K | Buy |
308
+78
| +34% | +$33.7K | ﹤0.01% | 3263 |
|
|
2019
Q2 | $274K | Sell |
230
-15
| -6% | -$17.9K | ﹤0.01% | 3082 |
|
|
2019
Q1 | $306K | Sell |
245
-137
| -36% | -$171K | ﹤0.01% | 3008 |
|
|
2018
Q4 | $362K | Buy |
382
+70
| +22% | +$66.3K | ﹤0.01% | 2901 |
|
|
2018
Q3 | $449K | Sell |
312
-105
| -25% | -$151K | ﹤0.01% | 2897 |
|
|
2018
Q2 | $674K | Sell |
417
-409
| -50% | -$661K | ﹤0.01% | 2830 |
|
|
2018
Q1 | $1.34M | Buy |
826
+707
| +594% | +$1.15M | ﹤0.01% | 2373 |
|
|
2017
Q4 | $200K | Buy |
+119
| New | +$200K | ﹤0.01% | 3249 |
|
|
2017
Q3 | – | Sell |
-171
| Closed | -$191K | – | 3695 |
|
|
2017
Q2 | $191K | Buy |
+171
| New | +$191K | ﹤0.01% | 3240 |
|
|
2014
Q3 | – | Sell |
-101
| Closed | -$85K | – | 4076 |
|
|
2014
Q2 | $85K | Buy |
+101
| New | +$85K | ﹤0.01% | 4131 |
|